StockNews.com initiated coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPT – Get Rating) (TSE:NTB) in a research note released on Thursday morning. The firm issued a sell rating on the biotechnology company’s stock.
Separately, Zacks Investment Research cut shares of Neptune Wellness Solutions from a buy rating to a hold rating in a report on Wednesday, April 13th.
NASDAQ:NEPT opened at $0.17 on Thursday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.07 and a current ratio of 1.75. The firm has a fifty day simple moving average of $0.23 and a two-hundred day simple moving average of $0.35. Neptune Wellness Solutions has a 12 month low of $0.16 and a 12 month high of $1.49.
Several hedge funds and other institutional investors have recently modified their holdings of NEPT. Virtu Financial LLC acquired a new position in shares of Neptune Wellness Solutions during the fourth quarter valued at about $64,000. Natixis purchased a new position in Neptune Wellness Solutions during the third quarter worth about $69,000. Morgan Stanley boosted its holdings in Neptune Wellness Solutions by 31.8% during the second quarter. Morgan Stanley now owns 141,269 shares of the biotechnology company’s stock worth $166,000 after purchasing an additional 34,123 shares during the last quarter. Renaissance Technologies LLC purchased a new position in Neptune Wellness Solutions during the fourth quarter worth about $184,000. Finally, Commonwealth Equity Services LLC boosted its holdings in Neptune Wellness Solutions by 7.1% during the first quarter. Commonwealth Equity Services LLC now owns 1,343,546 shares of the biotechnology company’s stock worth $298,000 after purchasing an additional 88,755 shares during the last quarter. Hedge funds and other institutional investors own 8.89% of the company’s stock.
Neptune Wellness Solutions Company Profile (Get Rating)
Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.
- Get a free copy of the StockNews.com research report on Neptune Wellness Solutions (NEPT)
- Skechers Stock Can Be Bought on Pullbacks
- ChemoCentryx: A Biotech Stock Well Worth the Risk
- Nasdaq Stock is a Buy the (Deep) Dip Opportunity
- Three Stocks To Ride Out A Rough Market
- MarketBeat: Week in Review 5/2 – 5/6
Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with MarketBeat.com's FREE daily email newsletter.